vs
EMPIRE PETROLEUM CORP（EP）与SUTRO BIOPHARMA, INC.（STRO）财务数据对比。点击上方公司名可切换其他公司
SUTRO BIOPHARMA, INC.的季度营收约是EMPIRE PETROLEUM CORP的1.6倍（$11.6M vs $7.1M），SUTRO BIOPHARMA, INC.同比增速更快（-21.4% vs -30.0%），过去两年SUTRO BIOPHARMA, INC.的营收复合增速更高（-5.4% vs -13.3%）
伊拉克石油公司，前身为土耳其石油公司，是一家石油企业，1925年至1961年间几乎垄断了伊拉克境内所有石油勘探与开采业务，由当时全球多家顶尖石油企业共同持股，公司总部设立于英国伦敦。
Sutro Biopharma是一家上市生物科技公司，总部位于加州南旧金山，专注于临床阶段药物的研发、开发与生产。公司依托自主专有的无细胞蛋白质合成平台，结合蛋白质工程与理性设计技术开发肿瘤治疗药物。公司2003年成立时名为Fundamental Applied Biology，2009年改用现名。
EP vs STRO — 直观对比
营收规模更大
STRO
是对方的1.6倍
$7.1M
营收增速更快
STRO
高出8.7%
-30.0%
两年增速更快
STRO
近两年复合增速
-13.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $7.1M | $11.6M |
| 净利润 | $-59.0M | — |
| 毛利率 | — | — |
| 营业利润率 | -834.5% | — |
| 净利率 | -835.1% | — |
| 营收同比 | -30.0% | -21.4% |
| 净利润同比 | -1306.0% | 35.4% |
| 每股收益（稀释后） | $-1.74 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EPSTRO
| Q4 25 | $7.1M | $11.6M | ||
| Q3 25 | $9.4M | $9.7M | ||
| Q2 25 | $8.8M | $63.7M | ||
| Q1 25 | $9.0M | $17.4M | ||
| Q4 24 | $10.1M | $14.8M | ||
| Q3 24 | $11.4M | $8.5M | ||
| Q2 24 | $12.8M | $25.7M | ||
| Q1 24 | $9.4M | $13.0M |
净利润EPSTRO
| Q4 25 | $-59.0M | — | ||
| Q3 25 | $-3.8M | $-56.9M | ||
| Q2 25 | $-5.1M | $-11.5M | ||
| Q1 25 | $-4.2M | $-76.0M | ||
| Q4 24 | $-4.2M | $-72.4M | ||
| Q3 24 | $-3.6M | $-48.8M | ||
| Q2 24 | $-4.4M | $-48.0M | ||
| Q1 24 | $-4.0M | $-58.2M |
营业利润率EPSTRO
| Q4 25 | -834.5% | — | ||
| Q3 25 | -37.8% | -499.9% | ||
| Q2 25 | -56.0% | -5.2% | ||
| Q1 25 | -43.9% | -393.8% | ||
| Q4 24 | -38.9% | -440.7% | ||
| Q3 24 | -30.0% | -797.2% | ||
| Q2 24 | -15.0% | -189.4% | ||
| Q1 24 | -46.8% | -435.0% |
净利率EPSTRO
| Q4 25 | -835.1% | — | ||
| Q3 25 | -40.9% | -586.6% | ||
| Q2 25 | -57.8% | -18.0% | ||
| Q1 25 | -46.9% | -436.6% | ||
| Q4 24 | -41.6% | -489.2% | ||
| Q3 24 | -32.0% | -572.6% | ||
| Q2 24 | -34.3% | -186.8% | ||
| Q1 24 | -42.3% | -447.5% |
每股收益（稀释后）EPSTRO
| Q4 25 | $-1.74 | — | ||
| Q3 25 | $-0.11 | $-0.67 | ||
| Q2 25 | $-0.15 | $-0.14 | ||
| Q1 25 | $-0.12 | $-0.91 | ||
| Q4 24 | $-0.12 | $-27.63 | ||
| Q3 24 | $-0.12 | $-0.59 | ||
| Q2 24 | $-0.15 | $-0.59 | ||
| Q1 24 | $-0.15 | $-0.59 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.2M | $141.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-4.6M | $-132.5M |
| 总资产 | $65.9M | $173.8M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资EPSTRO
| Q4 25 | $1.2M | $141.4M | ||
| Q3 25 | $4.6M | $167.6M | ||
| Q2 25 | $2.3M | $205.1M | ||
| Q1 25 | $1.1M | $249.0M | ||
| Q4 24 | $2.3M | $316.9M | ||
| Q3 24 | $3.1M | $388.3M | ||
| Q2 24 | $9.3M | $375.6M | ||
| Q1 24 | $3.5M | $267.6M |
总债务EPSTRO
| Q4 25 | — | — | ||
| Q3 25 | $15.2M | — | ||
| Q2 25 | $14.6M | — | ||
| Q1 25 | $11.6M | — | ||
| Q4 24 | $11.3M | — | ||
| Q3 24 | $8.5M | — | ||
| Q2 24 | $8.5M | — | ||
| Q1 24 | $8.5M | — |
股东权益EPSTRO
| Q4 25 | $-4.6M | $-132.5M | ||
| Q3 25 | $53.7M | $-87.3M | ||
| Q2 25 | $54.5M | $-32.1M | ||
| Q1 25 | $59.1M | $-25.8M | ||
| Q4 24 | $62.8M | $44.6M | ||
| Q3 24 | $56.5M | $111.2M | ||
| Q2 24 | $58.7M | $152.2M | ||
| Q1 24 | $31.7M | $98.0M |
总资产EPSTRO
| Q4 25 | $65.9M | $173.8M | ||
| Q3 25 | $123.0M | $209.7M | ||
| Q2 25 | $124.7M | $262.4M | ||
| Q1 25 | $123.7M | $321.4M | ||
| Q4 24 | $123.9M | $387.2M | ||
| Q3 24 | $121.2M | $451.8M | ||
| Q2 24 | $119.9M | $489.0M | ||
| Q1 24 | $100.1M | $403.4M |
负债/权益比EPSTRO
| Q4 25 | — | — | ||
| Q3 25 | 0.28× | — | ||
| Q2 25 | 0.27× | — | ||
| Q1 25 | 0.20× | — | ||
| Q4 24 | 0.18× | — | ||
| Q3 24 | 0.15× | — | ||
| Q2 24 | 0.15× | — | ||
| Q1 24 | 0.27× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.8M | $-177.2M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流EPSTRO
| Q4 25 | $-2.8M | $-177.2M | ||
| Q3 25 | $330.0K | $-38.2M | ||
| Q2 25 | $-3.1M | $-44.7M | ||
| Q1 25 | $1.6M | $-67.9M | ||
| Q4 24 | $-8.8M | $-71.7M | ||
| Q3 24 | $12.8M | $-64.5M | ||
| Q2 24 | $-1.8M | $9.5M | ||
| Q1 24 | $3.9M | $-64.7M |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
